Boston Scientific (BSX) Change in Receivables (2020 - 2026)

Boston Scientific's Change in Receivables history runs 7 years deep, the most recent figure standing at $117.0 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 9.35% year-over-year to $117.0 million; the TTM figure through Mar 2026 stood at $279.0 million (down 18.9% YoY), while the FY2025 annual figure was $269.0 million, down 23.36% from the prior year.
• Change in Receivables came in at $117.0 million for Q1 2026 at Boston Scientific, up from $98.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $117.0 million in Q1 2026 to a low of $3.0 million in Q3 2023.
• A 5-year average of $70.3 million and a median of $75.0 million in 2023 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables sank 78.57% in 2023 and surged 1000.0% in 2024, its largest moves.
• Boston Scientific's Change in Receivables stood at $44.0 million in 2022, then surged by 68.18% to $74.0 million in 2023, then rose by 21.62% to $90.0 million in 2024, then grew by 8.89% to $98.0 million in 2025, then gained by 19.39% to $117.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $117.0 million, $98.0 million, and $32.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison